Silverback Therapeutics, Inc.
ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF
Last updated:
Abstract:
ALK5 inhibitor compounds, conjugates, and pharmaceutical compositions for use in the treatment of disease, such as cancer, are disclosed herein. The disclosed compounds are useful, among other things, in the treating of cancer and fibrosis and modulating ALK5. Additionally, compounds incorporated into a conjugate with an antibody construct are described herein.
Status:
Application
Type:
Utility
Filling date:
16 Jul 2020
Issue date:
13 May 2021